Page last updated: 2024-11-01

nimodipine and Liver Dysfunction

nimodipine has been researched along with Liver Dysfunction in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaptanoglu, L1
Kapan, M1
Kapan, S1
Goksoy, E1
Oktar, H1

Other Studies

1 other study available for nimodipine and Liver Dysfunction

ArticleYear
Effects of nimodipine and pentoxyfylline in prevention of hepatic ischemic damage in rats at normal and hypothermic conditions.
    European journal of pharmacology, 2008, Jun-10, Volume: 587, Issue:1-3

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Calcium Channel Blockers; Hypothermia; L

2008